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Oligoribonucleotides (RNA) and modified oligonucleotides were subjected to low-energy
collision-induced dissociation in a hybrid quadrupole time-of-flight mass spectrometer to
investigate their fragmentation pathways. Only very restricted data are available on gas-phase
dissociation of oligoribonucleotides and their analogs and the fundamental mechanistic
aspects still need to be defined to develop mass spectrometry-based protocols for sequence
identification. Such methods are needed, because chemically modified oligonucleotides can
not be submitted to standard sequencing protocols.
In contrast to the dissociation of DNA, dissociation of RNA was found to be independent
of nucleobase loss and it is characterized by cleavage of the 5=-POO bond, resulting in the
formation of c- and their complementary y-type ions. To evaluate the influence of different
2=-substituents, several modified tetraribonucleotides were analyzed. Oligoribonucleotides
incorporating a 2=-methoxy-ribose or a 2=-fluoro-ribose show fragmentation that does not
exhibit any preferred dissociation pathway because all different types of fragment ions are
generated with comparable abundance. To analyze the role of the nucleobases in the
fragmentation of the phosphodiester backbone, an oligonucleotide lacking the nucleobase at
one position has been studied. Experiments indicated that the dissociation mechanism of RNA
is not influenced by the nucleobase, thus, supporting a mechanism where dissociation is
initiated by formation of an intramolecular cyclic transition state with the 2=-hydroxyl proton
bridged to the 5=-phosphate oxygen. (J Am Soc Mass Spectrom 2005, 16, 1262–1268) © 2005
American Society for Mass Spectrometry
Antisense oligonucleotides are nucleic acids ofabout 12 to 20 nucleobases, which are designedto hybridize to a complementary messenger
RNA (mRNA) sequence, thus, inhibiting gene expres-
sion [1-3]. Therefore, they are of great interest in human
cancer therapy and for diagnostic applications. Besides
the high binding specificity of antisense oligonucleo-
tides to their target mRNA, affinity, bioavailability, and
biostability are of foremost importance. However, a
major drawback of the application of unmodified phos-
phodiester DNA or RNA oligonucleotides is that these
structures are subjected to rapid nuclease degradation
under physiological conditions. To improve these fac-
tors, oligonucleotide analogs, exhibiting chemical mod-
ifications of the phosphodiester backbone, of the ribose,
and, to a limited extent, also of the nucleobases, are
evaluated.
Mechanisms of inhibition of gene expression by
antisense oligonucleotides involve mRNA degrading
enzymes such as RNase H, blockade of translation
initiation, or modulation of splicing [4-7]. These mech-
anisms allow the application of new chemical modifi-
cations to increase the binding affinity and the nuclease
resistance. Possible positions of the modifications are
the phosphodiester backbone, the sugar unit and the
nucleobases. Introduction of a phosphorothioate back-
bone increases nuclease resistance of antisense oligonu-
cleotides and simultaneously serves as a very efficient
substrate for mRNA degrading enzymes [6-9]. Unfortu-
nately, such modification reduces the binding affinity to
the complementary mRNA. Thus, further chemical
modifications (e.g., derivatization of the ribose 2=-posi-
tion by electronegative substituents) have been intro-
duced to increase the affinity and to further enhance
their nuclease resistance [10]. However, most of these
highly modified oligonucleotide analogs do not support
enzymatic activity and alternative mechanisms not re-
lying on RNase H activity are required.
Apart from the development of appropriate syn-
thetic methodologies, evaluation of oligonucleotide an-
alogs is among the main focuses of antisense research.
Evaluation of antisense oligonucleotides for therapeutic
and diagnostic applications requires suitable analytical
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tools for sequence determination and detailed struc-
tural elucidation. Because of the presence of unnatural
structural elements, the classical sequencing techniques
[11, 12] are likely to fail and alternative approaches for
rapid and accurate sequencing of chemically modified
oligonucleotides have to be developed. Tandem mass
spectrometry is a highly attractive candidate for this
task, because it is capable of providing the high degree
of structural information required.
Within the past decade, detailed mechanistic data on
the dissociation of unmodified oligodeoxyribonucleo-
tides (DNA) in gas-phase have been provided. The loss
of the nucleobase was found to be the initial dissocia-
tion step, leading to the subsequent cleavage of the
3=-COO bond, thus, resulting in the formation of the
generally abundant [a-B] and w ions. Several different
mechanisms have been proposed and evaluated to
explain the formation of the DNA typical [a-B] and w
fragment ions [13-15] and the generally applied nomen-
clature of oligonucleotide fragments was proposed by
McLuckey et al. in 1992 [16]. On the other hand, very
limited data are available on the dissociation of RNA
and oligonucleotide analogs.
Because of their use in antisense applications, meth-
ylphosphonate and phosphorothioate oligonucleotides
are among the most widely studied analogs. Oligonu-
cleotides with a methylphosphonate backbone have
been investigated to study the effect of backbone charge
on backbone dissociation and to trace the origin of the
proton transferred to the nucleobase as the initial step
of DNA dissociation [17, 18]. Oligonucleotides based on
the phosphorothioate backbone are highly promising
compounds for therapeutic antisense applications. The
first of these antisense oligonucleotides was admitted to
market in 1998 and further RNase H activating phos-
phorothioate oligonucleotides are currently in various
stages of clinical trial [3, 19-21]. Investigation of the
dissociation pattern of phosphorothioate, and phos-
phodiester oligodeoxyribonucleotides in gas-phase re-
vealed that both backbone modifications yield the same
types of fragment ions [22, 23].
Information on the fragmentation mechanism of
RNA in gas-phase is rare. The few reports found
indicate that dissociation of RNA clearly differs from
the dissociation of DNA. The preferred cleavage site of
RNA is the 5=-POO bond, resulting in the formation of
c- and y-type ions [24-26]. It has been shown that
oligoribonucleotides possess higher gas-phase stability
than oligodeoxyribonucleotides because of stabilization
of the N-glycosidic bond by the 2=-OH substituent [10,
27]. Unlike dissociation of DNA, backbone dissociation
of RNA is independent of nucleobase loss. Collision-
induced dissociation (CID) of mixed sequence DNA/
RNA oligonucleotides demonstrated that backbone
cleavage is controlled locally and influenced by the type
of adjacent ribose 2=-substituent. No evidence for any
remotely located group affecting the dissociation was
found and a fragmentation mechanism was proposed
[26]. Furthermore, the fragmentation patterns of differ-
ent 2=-ribose-modified oligonucleotides have been de-
scribed without focusing on the mechanistic aspects of
gas-phase dissociation [23, 28]. Reports specifically fo-
cusing on the dissociation mechanisms of 2=-modified
oligonucleotides and their gas-phase stability are miss-
ing completely.
In this article we report on the dissociation of selected
nucleobase- or 2=-ribose-modified oligonucleotides. To
gain insight into the fragmentation mechanism of oligori-
bonucleotides and for better understanding of the influ-
ence of different 2=-substituents, a number of selectively
modified oligoribonucleotides have been investigated by
electrospray tandem mass spectrometry on a hybrid
quadrupole time-of-flight mass spectrometer.
Experimental
Sample Preparation
RP-HPLC (reversed-phase high performance liquid
chromatography) purified oligonucleotides were ob-
tained from TriLink BioTechnologies (San Diego, CA)
and Microsynth (Balgach, Switzerland). The lyophilized
oligonucleotides were dissolved in a mixture of water/
acetonitrile/triethylamine (49/49/2) resulting in a final
oligonucleotide concentration of about 30 pmol/L.
Typically, a sample volume of 3 L was used for each
analysis.
Mass Spectrometry
All experiments were performed on an Applied Biosys-
tems/MDS Sciex QStar Pulsar hybrid quadrupole time-
of-flight mass spectrometer (Sciex, Concord, Canada),
equipped with a nanoelectrospray ion source (Protana,
Odense, Denmark). Oligonucleotides were analyzed in
the negative-ion mode with a potential of 900 V
applied to the nanospray needle. Nitrogen was used as
the curtain gas.
Tandem mass spectrometric experiments were per-
formed with precursor ions selected within a window
of 1.5 m/z units. CID was performed with collision
energies in the range of 10-35 eV using nitrogen as the
collision gas. The time-of-flight analyzer was tuned for
an average mass resolving power of 10,000 (full width
at half maximum) and calibrated externally using a
mixture of cesium iodide and taurocholic acid. Calibra-
tion was performed before each series of experiments or
at least once a day. The Applied Biosystems Analyst QS
software package was used for data processing. Product
ion spectra of tetranucleotides are based on the doubly
deprotonated precursor ions.
Results and Discussion
A partial section of the product ion spectra of the
tetranucleotides d(TATG) and UAUU is shown in Fig-
ure 1. It shows the unique fragment ion pattern of RNA,
which clearly differs from the pattern of DNA. The
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product ion spectrum of the doubly deprotonated tet-
radeoxyribonucleotide d(TATG) with m/z 593.13 is
shown in Figure 1a. The spectrum is characterized by
the abundant DNA typical w1, w2, and w3 fragment
ions with m/z 346.07, 650.13, and 963.20, respectively,
generated by cleavage of the 3=-COO bonds. The com-
plementary [a-B]-type ions and additional fragments
due to backbone cleavage at alternative positions and
nucleobase loss are observed with reduced abundance.
On the other hand, the product ion spectrum of the
tetraribonucleotide UAUU ([M-2H]2, m/z 591.63)
shows abundant y- and c-type ions (Figure 1b). Most of
the theoretically possible fragment ions originating
from backbone cleavage can be found in the spectrum.
The y2 ion (m/z 549.13) exhibits about a fourfold higher
abundance than the other 3=-terminal ions (w2, x2, and
z2). Likewise, the abundance of the c2 ion (m/z 634.12) is
about three times higher, compared with the alternative
5=-terminal fragment ions (a2, b2, and d2). The observed
formation of c- and their complementary y-type ions
confirms the 5=-POO bond as the preferred cleavage
site within the RNA backbone. RNA typical behavior
was also found for the first and third phosphodiester
group of the tetraribonucleotide (data not shown).
The different fragment ion patterns observed for
DNA and RNA must be related to the presence of the
altered 2=-substituent. The electronegative hydroxyl
group of RNA plays a key role in the dissociation
mechanism, because it effectively stabilizes the N-gly-
cosidic bond. The inductive effect of such a strong
electron-withdrawing group impedes formation of the
carbocation at the 1=-position [10], thus, rendering
nucleobase loss less prominent. Furthermore, the avail-
ability of the additional proton in the vicinity of the
phosphodiester group provides alternative pathways
for backbone cleavage.
To obtain mechanistic data on the gas-phase disso-
ciation of RNA and to evaluate the influence of different
2=-substituents on the dissociation and stability of the
N-glycosidic bond, a number of tetraribonucleotides
bearing a single modified nucleotide have been studied.
Modifications include 2=-methoxy and 2=-fluoro sub-
stituents at the 2=-position of the second nucleotide, and
a deoxynucleotide lacking the nucleobase (dSpacer) as
the third building block within the sequence (Scheme
1). Thus, the influence of the modifications on the
second phosphodiester group can be observed.
Tetramers were chosen for this study because they
can be dissociated efficiently under low-energy CID
conditions, and the length of the nucleotide sequences
is still sufficient to study the effect of selected local
modifications on backbone dissociation. Hydrogen/
deuterium exchange experiments, which are often used
for localizing the origin of protons transferred on dis-
sociation reactions, do not provide conclusive informa-
tion on the dissociation of RNA, because 2=-hydroxyl
protons, remaining phosphate protons on the backbone,
and amino protons of the nucleobases would be ex-
changed.
Compared with unmodified RNA, oligoribonucleo-
tides with a 2=-methoxy-adenosine as the second nucle-
otide exhibits a different fragmentation behavior, as
shown by the product ion spectrum of the doubly
deprotonated U(2=OMeA)UU (m/z 598.60) in Figure 2a.
Although the first and third phosphodiester groups
dissociate into RNA typical y- and c-type ions, no
evidence for a preferred dissociation pathway of the
second phosphodiester group was found, and all of the
theoretically possible fragment ions were observed with
similar abundance. This experiment shows that the
fragmentation mechanism of RNA is not exclusively
influenced by the stabilization of the N-glycosidic bond
b UAUU
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Figure 1. Comparison of the product ion spectra of DNA and
RNA. (a) Product ion spectrum of the deoxyribonucleotide
d(TATG), obtained by dissociation of the [M-2H]2 precursor ion
with m/z 593.13. The abundant w2 ion (m/z 650.13) is a result of the
cleavage of the 3=-COO bond, which is initiated by nucleobase
loss. (b) The product ion spectrum of the [M-2H]2 precursor ion
of the tetraribonucleotide UAUU (m/z 591.63) predominantly
shows the RNA characteristic y2 and c2 ions with m/z 549.13 and
634.12, respectively. Other fragments, because of backbone cleav-
age, are of significantly lower intensity.
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by the 2=-hydroxyl oxygen. The 2=-hydroxyl proton
most likely contributes to the formation of y- and c-type
ions as well. Otherwise, backbone dissociation next to
2=-methoxy-modified nucleotides would result in frag-
ment ion patterns identical to those of unmodified
nucleotides.
Figure 2b further shows the influence of an electro-
negative 2=-substituent on backbone dissociation. The
product ion spectrum obtained by dissociation of dou-
bly deprotonated U(2=FluoroA)UG (m/z 612.11), which
bears a 2=-fluoro modification at the second nucleotide,
is shown in Figure 2b. The stabilizing effect of the
electronegative 2=-substiuent on the N-glycosidic bond
reduces the rate of nucleobase loss and, consequently,
the abundance of the corresponding fragment ions is
decreased. Formation of the w2 ion (m/z 668.10) even
becomes less likely than the formation of the alternative
x2, y2, and z2 ions. Also, the complementary [a2-B2] ion
(m/z 444.09) is of significantly reduced abundance,
when compared with the dissociation pattern of an
unmodified DNA. The 2=-fluoro nucleotide does not
exhibit any preferred dissociation pathway, and the
various types of fragment ions are of comparable abun-
dance. The resulting fragment ion pattern is quite
similar to the one observed for 2=-methoxy derivatives
(Figure 2a). Although 2=-hydroxyl, 2=-methoxy, and
2=-fluoro substituents all stabilize the N-glycosidic
bond, the fragmentation patterns of 2=-methoxy- and
2=-fluoro-modified tetranucleotides, which lack the ex-
changeable 2=-proton, clearly differ from the one of
RNA. These experiments on oligonucleotides incorpo-
rating building blocks with modified 2=-substituents
show the important role the 2=-hydroxyl group is play-
ing in the dissociation of RNA. The electronegative
2=-hydroxyl group stabilizes the N-glycosidic bond and
simultaneously provides a mobile proton.
A mechanism explaining backbone dissociation of
RNA, which involves the 2=-hydroxyl proton, has been
proposed previously [26]. It proposes initiation of back-
bone dissociation by formation of an intramolecular
cyclic transition-state with the 2=-hydroxyl proton
bridged to the 5=-phosphate oxygen. Abstraction of the
2=-hydroxyl proton by the 5=-oxygen leads to dissocia-
tion of the 5=-POO bond and, finally, complementary c-
and y-type fragment ions are released. Subsequent
bond rearrangement leads to stable c-type fragment
ions (Scheme 2a). The aforementioned results obtained
from experiments with 2=-modified tetraribonucleotides
are consistent with this mechanism.
However, the possibility of an alternative gas-
phase dissociation mechanism, similar to the one
known for backbone cleavage of oligoribonucleotides
in solution, still could not be excluded. The mecha-
nism shown in Scheme 2b involves the 2=-hydroxyl
proton and leads to the same RNA characteristic y-
and c-type fragment ions as the mechanism shown in
Scheme 2a. Although in gas-phase there is no free


































































































Scheme 1. Structures of the tetraribonucleotides investigated. All oligonucleotides are shown in
completely deprotonated form. Unmodified RNA is shown on the left. Modifications are located
between the second and the third building block and include 2=-methoxy and 2=-fluoro substituents
and a deoxynucleotide lacking the nucleobase (dSpacer).
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deprotonation of the 2=-hydroxyl group could still be
accomplished by intramolecular proton transfer to
the adjacent 3=-nucleobase. Deprotonation of the 2=-
hydroxyl group would be followed by transesterifi-
cation, in which the 2=-oxygen participates as a nu-
cleophile, generating a cyclic transition-state. Bond
rearrangement and protonation of the leaving group
(y ion) by the protonated nucleobase would finally
result in cleavage of the phosphodiester backbone
and in the formation of the c- and its complementary
y-type fragment ions (Scheme 2b).
To verify such an alternative mechanism the tet-
ranucleotide UA(dSpacer)G, incorporating a deoxy
building block lacking the nucleobase (Scheme 1), has
been subjected to CID. Incorporation of the dSpacer into
the sequence enables evaluation of the role of the
nucleobase in the dissociation of the phosphodiester
backbone, because the dSpacer does not provide any
nucleobase, which could potentially act as an acceptor
for the 2=-hydroxyl proton. If the nucleobases were
involved in the dissociation of RNA (e.g., as protona-
tion sites), the presence of a building block lacking the
nucleobase would block such mechanism. The altered
fragmentation pathway should result in a product ion
pattern that differs from the one observed for RNA. If,
on the other hand, the nucleobase was not involved in
the mechanism, dissociation of the phosphodiester
backbone would not be affected by the dSpacer and c-
and y-type ions would be formed predominantly.
Figure 3 shows an enlarged section of the product
ion spectrum of the doubly deprotonated tetraribo-
nucleotide UA(dSpacer)G with m/z 548.11. It represents
the fragment ions generated by cleavage of the precur-
sor between the second ribonucleotide (A) and the
dSpacer. The RNA typical y2 fragment ion (m/z 462.12)
was observed with high abundance, whereas all alter-
native 3=-terminal fragment ions (x2, z2, and w2) were of
significantly decreased abundance, only reaching about
10-30% of the intensity of the y2 ion. Likewise, c2 (m/z
634.09) was the most abundant 5=-terminal fragment
ion. The product ion spectrum of the unmodified oligo-
ribonucleotide UAUU (Figure 1b) and the spectrum of
the modified sequence incorporating the dSpacer (Fig-
ure 3) both show similar fragment ion patterns with the
y- and c-type ions as the most abundant fragments. The
fragment ion pattern is independent of the presence of
the nucleobase. Consequently, the nucleobase does not
have any significant influence on the dissociation mech-
anism of oligoribonucleotides. An alternative mecha-
nism, in which the nucleobase plays a key role as
acceptor of the 2=-hydroxyl proton, can be eliminated.
These experiments clarify the role the nucleobases are
playing in the fragmentation mechanism of oligoribo-
nucleotides and confirm the previously proposed dis-
sociation mechanism of RNA [26], which suggests back-
bone dissociation to be initiated by formation of an
intramolecular cyclic transition-state with the 2=-hy-
droxyl proton bridged to the 5=-phosphate oxygen
(Scheme 2a), while the adjacent nucleobase is not in-
volved.
Conclusions
Investigation of oligoribonucleotides and their analogs
by tandem mass spectrometry establishes the impor-
tance of the 2=-hydroxyl substituent as the structural
key element in the fragmentation mechanism of RNA.
In contrast to DNA, which predominantly fragment
into [a-base]- and w-type ions, the presence of the
2=-hydroxyl group of RNA results in formation of
abundant c- and y-type ions. The electron-withdrawing
2=-substituent induces a stabilizing effect on the N-
glycosidic bond, thus, rendering nucleobase loss less
prominent. In addition, the availability of a proton in


















Figure 2. (a) Product ion spectrum of the doubly deprotonated
modified tetraribonucleotide U(2=-OMeA)UU with m/z 598.60. The
spectrum gives no evidence of a preferred dissociation pathway.
(b) Product ion spectrum of doubly deprotonated U(2=-Fluoro)UG
with m/z 612.11. The a2 fragment ion (m/z 556.10) is overlapped by
the very abundant [M-2H-HB(U)]2 ion.
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the vicinity of the phosphate group is mandatory for the
RNA typical backbone cleavage.
Experiments on oligoribonucleotides incorporat-
ing the dSpacer, a nucleotide lacking the nucleobase,
showed that gas-phase dissociation of the RNA back-
bone is not influenced by the nucleobases. Therefore,
a mechanism similar to the one known for backbone
cleavage of oligoribonucleotides in solution can be
eliminated. The results support the mechanism in
which backbone dissociation is initiated by formation
of an intramolecular cyclic transition-state with the
2=-hydroxyl proton bridged to the 5=-phosphate oxy-
gen.
Results provide fundamental information on the
gas-phase dissociation of oligoribonucleotides. This in-
formation is needed to provide the basis for reliable
tandem mass spectrometric sequencing methods, which
will greatly facilitate the identification and verification
of oligonucleotides and their analogs used for therapeu-
tic applications, as genetic probes or as primers for
amplification.
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Scheme 2. Dissociation mechanisms of RNA. (a) Previously proposed mechanism describing the dissoci-
ation of RNA. (b) Alternative dissociation mechanism similar to the one known for backbone cleavage of
oligoribonucleotides in solution. Both mechanisms include the 2=-hydroxyl proton and lead to the RNA-typical
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Figure 3. Product ion spectrum of the doubly deprotonated
UA(dSpacer)G (m/z 548.11), which incorporates a building block
lacking the nucleobase. The spectrum predominantly shows the
RNA characteristic y2 ion with m/z 462.12. Other fragments
indicate backbone cleavage at alternative positions.
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